Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma.

Subjects

Subjects :

Female
Humans
Male
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
ErbB Receptors genetics
Lung Neoplasms drug therapy
Mutation, Missense genetics
Quinazolines therapeutic use

Details

Language :

English

ISSN :

1556-1380

Volume :

10

Issue :

6

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Report

Accession number :

26001153

Full Text :

https://doi.org/10.1097/JTO.0000000000000538